Form 4 for IRON Disc Medicine, Inc.
Accepted 2022-06-02 00:00:00 ET · period of report 2022-05-31 · accession 0001209191-22-033719 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-02 | 2022-05-31 | IRON | Piekos Brian | CFO | A - Grant | $1.09 | +9,960 | 17.6K | +130% | +$10.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | A | A | 9,960 | $1.09 | 17,615 | D | — | — | (F2) In accordance with the terms of the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 31, 2022. |